OptiBiotix Health plc, a life sciences business, which develops compounds to tackle obesity, high cholesterol and diabetes, has proclaimed filing of two new patents covering its cholesterol reducing product thus making a hike in the number of patents from nine to eleven.

A deal in the form of a memorandum of understanding (MoU) between Pakistan Customs and Intellectual Property Organization (IPO) has been made to permit IPO acquire online data for execution of actions taken by the Pakistan Customs against illegal movement of goods imported or exported.

United Cannabis Corporation has pushed provisional patent application to the next phase in terms of filing a utility patent application and PCT application with the USPTO with respect to unique combinations of pharmaceutically active cannabinoids employed for the treatment of disorders of the nervous system, immune system and cancer

Cancer Genetics Inc., a budding leader in DNA-based cancer diagnostics, proclaimed receiving a third US patent covering FHACT (US patent number 9,157,129), its proprietary FISH (fluorescent in situ hybridization) based HPV associated cancer test and the granted patent is part of a sequence of patents received for FHACT that provide protections for CGI’s proprietary capabilities...

Rubicon Genomics Inc. has emerged as a world leader with respect to preparation and selling of kits and reagents that speed up genomic analysis, including DNA sequencing, with applications for gene-based research, drug development and diagnostics after going through a tough time in the recent past.

Patent filing by research institutes promotes their research works actively to the public domain. Since the patents can be licensed, it is therefore possible to derive financial value from them for conducting further researches. As the innovations evolving from institutes come out of strong fundamental knowledge, it is highly recommended to secure the same.

As part of the agreement, Ranbaxy along with its partners Cipher Pharm and Galephar Pharma, has entered into a non-exclusive license agreement with Actavis under the Dublin-headquartered company may start selling its generic version of Absorica in the US on 27 December 2020 (nine months before the expiration of the patents in September 2021) or...

In a relief for US drug major Merck Sharp and Dohme (MSD), Delhi High Court restrained Indian firm Glenmark Pharmaceuticals from manufacturing and selling its anti-diabetes drugs Zita and Zita-Met, saying it has infringed patent of the American company.

Apple Inc could be facing up to $862 million in damages after a U.S. jury on Tuesday found the iPhone maker used technology owned by the University of Wisconsin-Madison’s licensing arm without permission in chips found in many of its most popular devices.

The United States Patent and Trademark Office (USPTO) published a short Federal Register notice titled Change in Practice Regarding Correction of Foreign Priority Claims.